 |
|
Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab.
Kyung Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee
J Korean Ophthalmol Soc. 2017;58(1):62-68. Published online 2017 Jan 15 DOI: https://doi.org/10.3341/jkos.2017.58.1.62
|
|
Citations to this article as recorded by
 One-year Outcomes of a Treat-and-extend of Ranibizumab for Naive Exudative Age-related Macular Degeneration: Retrospective Analysis
Young-Je Choi, Woong-Sun Yoo, Yong-Wun Cho, Yu-Jin Choi, In Young Chung
Journal of the Korean Ophthalmological Society.2021; 62(7): 939. CrossRef Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(9): 1218. CrossRef Up-to-date knowledge on age-related macular degeneration
Kyoung Lae Kim, Sung Pyo Park
Journal of the Korean Medical Association.2018; 61(7): 416. CrossRef Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome
Jae Wook Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jung Il Han, Young Ju Lew, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2017; 58(9): 1042. CrossRef
|